Literature DB >> 2796413

Treatment modality and quality differences for black and white breast-cancer patients treated in community hospitals.

P Diehr1, J Yergan, J Chu, P Feigl, G Glaefke, R Moe, M Bergner, J Rodenbaugh.   

Abstract

This study assessed the relationship of race and patterns of care, defined by an expert NCI-appointed committee, for 7,781 patients with breast cancer treated in 107 hospitals in 45 communities between 1982 and 1985. After control for age and stage of disease, black patients had significantly different care from white patients for four of the ten patterns examined. They were less likely to have a progesterone receptor assay or to be referred for postmastectomy rehabilitation, two patterns deemed desirable for all patients. Black patients were also more likely to receive liver scans and radiation therapy in situations in which these procedures were labeled "less appropriate (as defined in the text)." Black patients differed significantly from whites on their health insurance, hospital, and physician characteristics; these factors were also significantly associated with the patterns of care. However, after controlling for these variables, the association between race and care persisted for three patterns. The patterns that showed racial differences were not the most clinically significant of the ten studied. Different treatment for black and white patients may help to explain differences in survival rates of black and white women with breast cancer.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2796413     DOI: 10.1097/00005650-198910000-00005

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  24 in total

1.  When should we delay highly active antiretroviral therapy?

Authors:  D R Bangsberg; A Moss
Journal:  J Gen Intern Med       Date:  1999-07       Impact factor: 5.128

2.  Race, medicine, and health care in the United States: a historical survey.

Authors:  W M Byrd; L A Clayton
Journal:  J Natl Med Assoc       Date:  2001-03       Impact factor: 1.798

3.  The prognostic significance of race and survival from laryngeal carcinoma.

Authors:  M Roach; M Alexander; J L Coleman
Journal:  J Natl Med Assoc       Date:  1992-08       Impact factor: 1.798

4.  Racial variation in end-of-life intensive care use: a race or hospital effect?

Authors:  Amber E Barnato; Zekarias Berhane; Lisa A Weissfeld; Chung-Chou H Chang; Walter T Linde-Zwirble; Derek C Angus
Journal:  Health Serv Res       Date:  2006-12       Impact factor: 3.402

5.  Cancer in the African American. The annual William E. Allen, Jr, MD, Memorial Lecture.

Authors:  C M Mansfield
Journal:  J Natl Med Assoc       Date:  1992-07       Impact factor: 1.798

6.  Hospital-level racial disparities in acute myocardial infarction treatment and outcomes.

Authors:  Amber E Barnato; F Lee Lucas; Douglas Staiger; David E Wennberg; Amitabh Chandra
Journal:  Med Care       Date:  2005-04       Impact factor: 2.983

7.  Obesity and hypertension among African Americans: do African-American primary care providers address these conditions when secondary to primary illness?

Authors:  E H Johnson; D Brandsond; J Everett; C M Lollis
Journal:  J Natl Med Assoc       Date:  1996-04       Impact factor: 1.798

8.  Hepatitis C virus infection in San Francisco's HIV-infected urban poor.

Authors:  Christopher S Hall; Edwin D Charlebois; Judith A Hahn; Andrew R Moss; David R Bangsberg
Journal:  J Gen Intern Med       Date:  2004-04       Impact factor: 5.128

9.  Medicare breast surgery fees and treatment received by older women with localized breast cancer.

Authors:  Jack Hadley; Jeanne S Mandelblatt; Jean M Mitchell; Jane C Weeks; Edward Guadagnoli; Yi-Ting Hwang
Journal:  Health Serv Res       Date:  2003-04       Impact factor: 3.402

10.  Social factors, treatment, and survival in early-stage non-small cell lung cancer.

Authors:  H P Greenwald; N L Polissar; E F Borgatta; R McCorkle; G Goodman
Journal:  Am J Public Health       Date:  1998-11       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.